Jump to content

One Last Look 5/19/20


Recommended Posts

  • Replies 64
  • Created
  • Last Reply

Just One Look 

We knew this was coming. $265 billion in MBS settlements for May are almost done. Now we reap the whirlwind. Here’s what to expect and why it’s time to GTFO.

Subscribers, click here to download the report

Not a subscriber yet?

90 Days Risk Free If You Join Now!

Get this report and access to all past and future reports risk free for 90 days! 

Link to comment
Share on other sites

Regarding Moderna's vaccine:

 

https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine

 

"All participants ages 18-55 (n=15 per cohort) across all three dose levels seroconverted by day 15 after a single dose"

 

All we have so far is a press release. I wouldn’t put much weight on that. We’ll need to wait for their results to get published. Then review it. An RNA vaccine like this has never been approved for human use but it has been successfully used with animals. But the bar is much lower for animals – you don’t care if a few die. This is a risky approach. They take the genome of the virus and then snip out the mRNA for just the S protein which binds to ACE2. Then they use a vector to get the mRNA into the human cells so it is expressed and some cells will translate the mRNA’s codons into the amino acid peptide of the S protein and present it on the cell surface. Those S proteins will be detected by the IgM antibody on a B-Cell surface and start the cascade of events that leads to production of protective IgG antibodies. The human cells will be seen as infected and will be killed. So you do lose a little bit of tissue. Some will feel as if they have the flu. You hope the correct mRNA is included and you don’t accidentally introduce the whole genome of the virus. And the IgG will probably last for two years. But if you get ADE after the virus mutates then this could result in a much worse illness later on. But we don’t know if ADE will happen. Generally a safer method is to just produce S protein on a wet bench and inject just the S protein to form an immune response but when this was tried with SARS it made the disease worse not better. Live attenuated viruses were tested for SARS but they reverted to wild type and killed the host. Risky stuff! Let’s hope we don’t cut safety corners and mandate and unsafe vaccine. But there is hope this could work.    

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

  • Tell a friend

    Love Stool Pigeons Wire Message Board? Tell a friend!
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • ×
    • Create New...